Production (Stage)
Ernexa Therapeutics Inc.
ERNA
$2.29
-$0.08-3.38%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -62.51% | -77.17% | -6.31% | 40.77% | -5.21% |
| Total Receivables | -55.56% | 2.82% | -89.47% | -76.83% | -45.75% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -80.34% | -88.37% | -60.37% | -28.13% | 47.98% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -64.13% | -75.50% | -32.73% | -7.92% | -5.39% |
|
|
|||||
| Total Current Assets | -64.13% | -75.50% | -32.73% | -7.92% | -5.39% |
| Net Property, Plant & Equipment | -98.16% | -97.73% | -97.65% | 3.08% | 2,992.52% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -97.20% | -97.20% | -98.53% | -22.93% | -21.02% |
| Total Assets | -89.81% | -89.28% | -85.23% | -1.00% | 228.68% |
|
|
|||||
| Total Accounts Payable | -38.20% | 61.29% | 49.80% | -18.02% | 41.20% |
| Total Accrued Expenses | -37.20% | -65.03% | -49.46% | -38.09% | -31.92% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -92.59% | -90.66% | -82.51% | 2,365.90% | 1,610.71% |
| Total Finance Division Other Current Liabilities | 692.00% | -99.27% | -74.81% | 19.95% | 10.66% |
| Total Other Current Liabilities | 692.00% | -99.27% | -74.81% | 19.95% | 10.66% |
| Total Current Liabilities | 34.37% | -55.30% | 3.39% | 33.98% | 43.69% |
|
|
|||||
| Total Current Liabilities | 34.37% | -55.30% | 3.39% | 33.98% | 43.69% |
| Long-Term Debt | -- | -- | 828.07% | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -98.85% | -98.55% | -98.47% | 3.09% | 4,247.80% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -78.95% | -78.11% | 1,635.74% | -50.73% | -51.25% |
| Total Liabilities | -79.26% | -92.39% | 9.09% | 27.67% | 586.71% |
|
|
|||||
| Common Stock & APIC | 22.91% | 23.27% | -2.17% | 6.45% | 6.81% |
| Retained Earnings | -23.81% | -23.83% | -24.86% | -13.66% | -13.42% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -74.36% | -23.84% | -1,374.75% | -320.62% | -146.25% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
|
|
|||||
| Total Common Equity | -74.36% | -23.84% | -1,374.75% | -320.62% | -146.25% |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -74.38% | -23.82% | -1,374.37% | -320.54% | -146.23% |
|
|
|||||